China Biopharmaceutical (01177) issued an announcement. On April 8, 2024, the trustee purchased 6 more from the market...
According to the Zhitong Finance App, China Biopharmaceutical (01177) issued an announcement. On April 8, 2024, the trustee purchased a further 6.75 million shares from the market and held them in trust on behalf of the selected participants in accordance with the terms and conditions of the plan rules. The average cost per share is approximately HK$2.83.